Preconditioning with triiodothyronine improves the clinical signs and acute tubular necrosis induced by ischemia/reperfusion in rats.
BACKGROUND: Renal ischemia/reperfusion (I/R) injury is manifested by acute renal failure (ARF) and acute tubular necrosis (ATN). The aim of this study was to evaluate the effectiveness of preconditioning with 3, 3, 5 triiodothyronine (T3) to prevent I/R renal injury. METHODOLOGY/PRINCIPAL FINDINGS:...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3784446?pdf=render |
id |
doaj-3bffbec669b84d5ab19587c3fc78a6eb |
---|---|
record_format |
Article |
spelling |
doaj-3bffbec669b84d5ab19587c3fc78a6eb2020-11-25T00:47:26ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0189e7496010.1371/journal.pone.0074960Preconditioning with triiodothyronine improves the clinical signs and acute tubular necrosis induced by ischemia/reperfusion in rats.Carla FerreyraFélix VargasIsabel Rodríguez-GómezRocío Pérez-AbudFrancisco O'ValleAntonio OsunaBACKGROUND: Renal ischemia/reperfusion (I/R) injury is manifested by acute renal failure (ARF) and acute tubular necrosis (ATN). The aim of this study was to evaluate the effectiveness of preconditioning with 3, 3, 5 triiodothyronine (T3) to prevent I/R renal injury. METHODOLOGY/PRINCIPAL FINDINGS: The rats were divided into four groups: sham-operated, placebo-treated (SO-P), sham-operated T3- treated (SO- T3), I/R-injured placebo-treated (IR-P), and I/R-injured T3-treated (IR- T3) groups. At 24 h before ischemia, the animals received a single dose of T3 (100 μg/kg). Renal function and plasma, urinary, and tissue variables were studied at 4, 24, and 48 h of reperfusion, including biochemical, oxidative stress, and inflammation variables, PARP-1 immunohistochemical expression, and ATN morphology. In comparison to the SO groups, the IR-P groups had higher plasma urea and creatinine levels and greater proteinuria (at all reperfusion times) and also showed: increased oxidative stress-related plasma, urinary, and tissue variables; higher plasma levels of IL6 (proinflammatory cytokine); increased glomerular and tubular nuclear PARP-1 expression; and a greater degree of ATN. The IR-T3 group showed a marked reduction in all of these variables, especially at 48 h of reperfusion. No significant differences were observed between SO-P and SO-T3 groups. CONCLUSIONS: This study demonstrates that preconditioning rats with a single dose of T3 improves the clinical signs and ATN of renal I/R injury. These beneficial effects are accompanied by reductions in oxidative stress, inflammation, and renal PARP-1 expression, indicating that this sequence of factors plays an important role in the ATN induced by I/R injury.http://europepmc.org/articles/PMC3784446?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Carla Ferreyra Félix Vargas Isabel Rodríguez-Gómez Rocío Pérez-Abud Francisco O'Valle Antonio Osuna |
spellingShingle |
Carla Ferreyra Félix Vargas Isabel Rodríguez-Gómez Rocío Pérez-Abud Francisco O'Valle Antonio Osuna Preconditioning with triiodothyronine improves the clinical signs and acute tubular necrosis induced by ischemia/reperfusion in rats. PLoS ONE |
author_facet |
Carla Ferreyra Félix Vargas Isabel Rodríguez-Gómez Rocío Pérez-Abud Francisco O'Valle Antonio Osuna |
author_sort |
Carla Ferreyra |
title |
Preconditioning with triiodothyronine improves the clinical signs and acute tubular necrosis induced by ischemia/reperfusion in rats. |
title_short |
Preconditioning with triiodothyronine improves the clinical signs and acute tubular necrosis induced by ischemia/reperfusion in rats. |
title_full |
Preconditioning with triiodothyronine improves the clinical signs and acute tubular necrosis induced by ischemia/reperfusion in rats. |
title_fullStr |
Preconditioning with triiodothyronine improves the clinical signs and acute tubular necrosis induced by ischemia/reperfusion in rats. |
title_full_unstemmed |
Preconditioning with triiodothyronine improves the clinical signs and acute tubular necrosis induced by ischemia/reperfusion in rats. |
title_sort |
preconditioning with triiodothyronine improves the clinical signs and acute tubular necrosis induced by ischemia/reperfusion in rats. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2013-01-01 |
description |
BACKGROUND: Renal ischemia/reperfusion (I/R) injury is manifested by acute renal failure (ARF) and acute tubular necrosis (ATN). The aim of this study was to evaluate the effectiveness of preconditioning with 3, 3, 5 triiodothyronine (T3) to prevent I/R renal injury. METHODOLOGY/PRINCIPAL FINDINGS: The rats were divided into four groups: sham-operated, placebo-treated (SO-P), sham-operated T3- treated (SO- T3), I/R-injured placebo-treated (IR-P), and I/R-injured T3-treated (IR- T3) groups. At 24 h before ischemia, the animals received a single dose of T3 (100 μg/kg). Renal function and plasma, urinary, and tissue variables were studied at 4, 24, and 48 h of reperfusion, including biochemical, oxidative stress, and inflammation variables, PARP-1 immunohistochemical expression, and ATN morphology. In comparison to the SO groups, the IR-P groups had higher plasma urea and creatinine levels and greater proteinuria (at all reperfusion times) and also showed: increased oxidative stress-related plasma, urinary, and tissue variables; higher plasma levels of IL6 (proinflammatory cytokine); increased glomerular and tubular nuclear PARP-1 expression; and a greater degree of ATN. The IR-T3 group showed a marked reduction in all of these variables, especially at 48 h of reperfusion. No significant differences were observed between SO-P and SO-T3 groups. CONCLUSIONS: This study demonstrates that preconditioning rats with a single dose of T3 improves the clinical signs and ATN of renal I/R injury. These beneficial effects are accompanied by reductions in oxidative stress, inflammation, and renal PARP-1 expression, indicating that this sequence of factors plays an important role in the ATN induced by I/R injury. |
url |
http://europepmc.org/articles/PMC3784446?pdf=render |
work_keys_str_mv |
AT carlaferreyra preconditioningwithtriiodothyronineimprovestheclinicalsignsandacutetubularnecrosisinducedbyischemiareperfusioninrats AT felixvargas preconditioningwithtriiodothyronineimprovestheclinicalsignsandacutetubularnecrosisinducedbyischemiareperfusioninrats AT isabelrodriguezgomez preconditioningwithtriiodothyronineimprovestheclinicalsignsandacutetubularnecrosisinducedbyischemiareperfusioninrats AT rocioperezabud preconditioningwithtriiodothyronineimprovestheclinicalsignsandacutetubularnecrosisinducedbyischemiareperfusioninrats AT franciscoovalle preconditioningwithtriiodothyronineimprovestheclinicalsignsandacutetubularnecrosisinducedbyischemiareperfusioninrats AT antonioosuna preconditioningwithtriiodothyronineimprovestheclinicalsignsandacutetubularnecrosisinducedbyischemiareperfusioninrats |
_version_ |
1725259988202422272 |